Glovista Investments’s Zimmer Biomet ZBH Stock Holding History

Glovista Investments’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,966	Closed	-$429K	–	120
2018 Q2	$429K	Sell	3,966 -1,236	-24%	-$135K	0.11%	83
2018 Q1	$551K	Sell	5,202 -566	-10%	-$65.7K	0.12%	59
2017 Q4	$676K	Sell	5,768 -206	-3%	-$23.3K	0.13%	62
2017 Q3	$679K	Buy	5,974 +103	+2%	+$11.9K	0.13%	68
2017 Q2	$732K	Sell	5,871 -103	-2%	-$12.2K	0.16%	64
2017 Q1	$708K	Buy	+5,974	New	+$677K	0.16%	69

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Glovista Investments's ZBH Position: Q3 2018 in Review

Glovista Investments sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 3,966 shares — an estimated $429K sold.

Glovista Investments first reported a position in ZBH in Q1 2017 and held it in 6 quarters. The position peaked at $732K in Q2 2017. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

Glovista Investments reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
Glovista Investments sold 3,966 Zimmer Biomet shares in Q3 2018, an estimated $429K.
Glovista Investments first reported a position in Zimmer Biomet in Q1 2017 and held it in 6 quarters.
Glovista Investments's Zimmer Biomet position peaked at $732K in Q2 2017.
891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Glovista Investments's 13F filing for Q3 2018, filed 14 Nov 2018.